The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries
- Conditions
- Fracture of Foot
- Interventions
- Procedure: BFR+NMES at therapeutic levelProcedure: BFR+NMES at sub therapeutic level
- Registration Number
- NCT05844280
- Lead Sponsor
- University of Alabama at Birmingham
- Brief Summary
The purpose of the study is to determine the role of blood flow restriction (BFR) + neuromuscular electrical stimulation (NMES) in improving post-operative physical therapy and recovery after ankle fracture surgery. We expect to see improved muscle strength, less muscle wasting, and improved functional recovery after surgery when making these additions to routine post-operative (postop) physical therapy protocols.
- Detailed Description
Few studies have examined BFR in patients sustaining operative foot and ankle injuries. Due to the weight bearing limitations and prolonged immobilization following these injuries, patients often experience increased time away from work and delays with return to sport. These factors are responsible for the rapid muscle atrophy that occurs in the immediate post injury period because of immobility and disuse. Recently, blood flow restriction (BFR) therapy has been shown to be effective in improving muscle strength and preventing atrophy when combined with low load resistance training physical therapy programs.7,8 Neuromuscular electrical stimulation (NMES) is an adjunctive agent that has been show to augment the effects of BFR alone.4 The null hypothesis is that a 2 week BFR + NMES + low load resistance training program in patients age \>= 18 recovering from foot and ankle surgery will have no effect on short term (2 weeks postop) lower extremity muscle hypertrophy or atrophy, patient pain and satisfaction, or functional recovery after foot and ankle surgery.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 28
- isolated, closed low-energy rotational ankle fracture without prior surgery or implants to injured area
- history of Deep Vein Thrombosis in affected extremity
- history of significant cardiac disease defined as a recent stent placement in past
- history of peripheral arterial disease
- history of sickle cell disease
- history of coagulopathy
- presenting to surgery >14 days after injury
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Group BFR+NMES at therapeutic level receiving physical therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic Control Group BFR+NMES at sub therapeutic level receiving physical therapy with BFR+NMES devices used at sub-therapeutic levels
- Primary Outcome Measures
Name Time Method Assess for calf muscle atrophy as measured by calf circumference 2 weeks postop Calf circumference will be measured using a measuring tape
Assess for calf muscle atrophy as measured by hand held dynamometry 2 weeks postop Hand held Dynamometry will be used to measure the length-tension relationship of the muscle in pounds
- Secondary Outcome Measures
Name Time Method Patient tolerance of the BFR treatment using the Visual Analogue Pain Scale. 2 weeks postop The Visual Analogue Pain Scale is used during the beginning, midpoint, and end of a session.
This scale ranges from 0-10 which 0 being "no pain" and 10 being "worst pain"Patient tolerance of the BFR treatment using the the Borg Rating of Perceived Exertion f 2 weeks postop The Borg Rating of Perceived Exertion will be used for each session and exercise.
This rating ranges from 6-20 with 6 being no exertion at all, and 20 being maximum effort
Trial Locations
- Locations (1)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States